Form EFFECT Scinai Immunotherapeutic
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 28, 2026 |
| Accession Number: | 0001213900-26-094234 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SHARx Warns PBM Rebate Reform May Move Money Without Lowering Employer Costs
- rhino.ai Launches rhino Agentic Mainframe Modernization on AWS, Giving Enterprises a Complete Blueprint to Modernize Beyond the Mainframe
- American Rare Earths' Letter to Shareholders
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
